Get the Stockscreener App
8.17
2.85%
-0.24
After Hours:
8.17
Omeros Corporation Stock (OMER) Latest News
Investor Network: Omeros Corporation to Host Earnings Call - ACCESS Newswire
Blue Trust Inc. Sells 1,910 Shares of Omeros Co. (NASDAQ:OMER) - Defense World
Loss-Making Omeros Corporation (NASDAQ:OMER) Expected To Breakeven In The Medium-Term - Simply Wall St
Omeros Corporation: Scientifically Compelling Again, But The Delay Has Cost Us (OMER) - Seeking Alpha
Trading (OMER) With Integrated Risk Controls - Stock Traders Daily
Omeros Corporation Announces Statistical Analysis Results for Expanded Access ProgramSeattle, Washington–(BUSINESS WIRE)–Feb 20, 2025–Omeros Corporation (NASDAQ: OMER) announced today the statistical analysis results related to the expande - Defense World
Omeros announces results for narsoplimab expanded access program - Yahoo Finance
Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA - Business Wire
Can This Drug Cut Death Risk by 66% in Transplant Patients? New Data Reveals Breakthrough - StockTitan
Brokerages Set Omeros Co. (NASDAQ:OMER) Price Target at $22.50 - MarketBeat
Omeros Corporation Announces Availability on its Website of Materials Accompanying Narsoplimab Presentations at the 2025 Tandem Meetings - Business Wire
Breakthrough TA-TMA Treatment Data: Narsoplimab Shows Promising Results in 128-Patient Study - StockTitan
Omeros Co. (NASDAQ:OMER) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program - BioSpace
Omeros Corporation Announces Upcoming Presentations Detailing Outcomes Of Narsoplimab Treatment For Ta-Tma - Marketscreener.com
Institutions own 43% of Omeros Corporation (NASDAQ:OMER) shares but retail investors control 53% of the company - Yahoo Finance
SG Americas Securities LLC Has $241,000 Position in Omeros Co. (NASDAQ:OMER) - Defense World
Navigating OMER Stock: Omeros Corporation Journey - The InvestChronicle
Stordahl Capital Management Inc. Purchases New Shares in Omeros Co. (NASDAQ:OMER) - MarketBeat
Omeros (NASDAQ:OMER) Trading Up 5.3%Here's What Happened - MarketBeat
Omeros (NASDAQ:OMER) Stock Price Down 4.4%Here's Why - MarketBeat
Omeros jumps as lead drug succeeds in pivotal trial for blood transplant patients - MSN
Cantor Fitzgerald Forecasts Omeros FY2025 Earnings - Defense World
Omeros (NASDAQ:OMER) Shares Gap DownTime to Sell? - MarketBeat
Cantor Fitzgerald Comments on Omeros FY2025 Earnings - MarketBeat
Omeros’ (OMER) Hold Rating Reiterated at Needham & Company LLC - Defense World
Barclays PLC Acquires 51,873 Shares of Omeros Co. (NASDAQ:OMER) - MarketBeat
Barclays PLC Has $376,000 Holdings in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros (NASDAQ:OMER) Earns “Buy” Rating from D. Boral Capital - Defense World
Omeros Corporation Announces Statistical Sensitivity Analyses Results for Narsoplimab - Defense World
Needham & Company LLC Reaffirms Hold Rating for Omeros (NASDAQ:OMER) - MarketBeat
Omeros (NASDAQ:OMER) Stock Price Up 5.5%Time to Buy? - MarketBeat
D. Boral Capital Reiterates Buy Rating for Omeros (NASDAQ:OMER) - MarketBeat
Narsoplimab shows promise in reducing mortality for TA-TMA patients - MSN
Omeros Co. (NASDAQ:OMER) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Omeros Co. (NASDAQ:OMER) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Personal Finance - Business Wire
Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint - Business Wire
Jane Street Group LLC Has $231,000 Stock Holdings in Omeros Co. (NASDAQ:OMER) - Defense World
When the Price of (OMER) Talks, People Listen - Stock Traders Daily
Mydriasis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Viatris/Ocuphire Pharma, Eyenovia, Rayner Surgical/Omeros, Eyenovia Inc - The Globe and Mail
United Rentals (URI-N) QuotePress Release - The Globe and Mail
Omeros (NASDAQ:OMER) Stock Price Down 3.1%Time to Sell? - MarketBeat
Geode Capital Management LLC Has $5.32 Million Position in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros Co. (NASDAQ:OMER) Shares Acquired by Barclays PLC - Defense World
Omeros (NASDAQ:OMER) Trading Up 10.3%Time to Buy? - MarketBeat
Omeros (NASDAQ:OMER) Shares Gap UpShould You Buy? - MarketBeat
State Street Corp Has $4.87 Million Stock Position in Omeros Co. (NASDAQ:OMER) - Defense World
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):